Monoferric(R) (Ferric Derisomaltose) Injection Is Approved by the US FDA for the Treatment of Iron Deficiency Anemia

MORRISTOWN, N.J., Jan. 29, 2020 -- (Healthcare Sales & Marketing Network) -- Pharmacosmos Therapeutics Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Monoferric® (ferric derisomaltose) injection 100 mg/mL. M... Biopharmaceuticals, FDA Pharmacosmos Therapeutics, Monoferric, ferric derisomaltose, anemia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news